Biopolym. Cell. 2017; 33(5):323-334.
Nitric oxide as the main multifunctional regulator of immunocompetent and endothelial cells
1Sadlyak O. V., 1Kolishetska M. A., 1Baida M. L., 1Musij-Sementsiv Kh. G., 1Sementsiv N. G., 1Lesyk R. B.
  1. Danylo Halytsky Lviv National Medical University
    69, Pekarska Str., Lviv, Ukraine, 79010


Nitric oxide (NO) plays an important role in metabolism. Consequently, every tissue of our body is affected by changes in concentrations of nitric oxide and its metabolites. Here we analyze phenotypic effects of NO and its metabolites in macrophages, NK-cells and lymphocytes that perform protection of the host organism against malignant tumors and intracellular pathogens. Immune system imbalance may result from misregulation of NO synthesis. Nitric oxide also plays an important role in endothelial dysfunction including inhibition of platelet adhesion and aggregation, vasoconstriction and vasodilation disorders of blood vessels, blood rheology changes and the development of atherosclerotic plaques. Thus an imbalance in the synthesis of nitric oxide in the vascular endothelium may be an early marker of lesions of various origins.
Keywords: NO-synthases, lymphocytes, immune system, inflammation, endothelial dysfunction, endotheliocytes


[1] Pacher P, Beckman JS, Liaudet L. Nitric oxide and peroxynitrite in health and disease. Physiol Rev. 2007;87(1):315-424.
[2] Niedbala W, Wei XQ, Piedrafita D, Xu D, Liew FY. Effects of nitric oxide on the induction and differentiation of Th1 cells. Eur J Immunol. 1999;29(8):2498-505.
[3] Solovyov AI. Metamorphosis in "family" of nitric oxide. From the origin of life on earth to apoptosis and regulation of cellular functions and communications. Likyvannya i diagnostyka. 2003; (3):8–14.
[4] Gómez-Guerrero C, López-Franco O, Suzuki Y, Sanjuán G, Hernández-Vargas P, Blanco J, Egido J. Nitric oxide production in renal cells by immune complexes: Role of kinases and nuclear factor-kappaB. Kidney Int. 2002;62(6):2022-34.
[5] Sepiashvili RI. The functional immune system homeostasis. Allergology and Immunology. 2002; 4(2): 5–14.
[6] Ahsan H, Ali A, Ali R. Oxygen free radicals and systemic autoimmunity. Clin Exp Immunol. 2003;131(3):398-404.
[7] Hart SP, Alexander KM, Dransfield I. Immune complexes bind preferentially to Fc gamma RIIA (CD32) on apoptotic neutrophils, leading to augmented phagocytosis by macrophages and release of proinflammatory cytokines. J Immunol. 2004;172(3):1882-7.
[8] Babii VP. NO-dependent mechanisms of leukocyte emigration: PhD thesis med Sci: 14.03.04. Odessa Medical University. Odessa, 2004; 18 p.
[9] McIntyre TM, Prescott SM, Weyrich AS, Zimmerman GA. Cell-cell interactions: leukocyte-endothelial interactions. Curr Opin Hematol. 2003;10(2):150-8.
[10] Ignatieva GA. Sovremennyye predstavleniya ob immunitete. (kontury obshchey teorii). Patol Physiol Eksp Terp. 2003; 2: 2–7.
[11] Sepiashvili RI, Shubich MG, Karpyuk VB. Nitric oxide in asthma and various forms of immunopathology. Astma. 2001; 2 (1): 5–14.
[12] Adamenko GP. Cooperative interaction of poly- and mononuclear phagocytes: the effect of co-culturing cells on their chemiluminescence and secretion of myeloperoxidase. Immunologiya. 2000; 4: 26–29.
[13] Dushianthan A, Grocott MP, Postle AD, Cusack R. Acute respiratory distress syndrome and acute lung injury. Postgrad Med J. 2011;87(1031):612-22.
[14] Yarilin AA. Symbiotic relationships of the immune system cells. Immunologia. 2001; 25(4): 16–20.
[15] Zalessky VN, Phylchenkov AA Dynnik OB. Methods for visualizations of apoptosis. Journal of National Academy of Medical Sciences. 2004; 10(2): 326–38.
[16] Sombra MA, Vasconcelos MP, Guimarães SB, Escalante RD, Garcia JH, Vasconcelos PR. Acute pulmonary injury induced by experimental muscle trauma. Acta Cir Bras. 2011;26 Suppl 1:43-6.
[17] Sepiashvili RI, Balmasova IP. Physiological basies of operation of the new -lymphocyte subpopulations. Allerg Immunolog. 2003; 4(2): 5–14.
[18] Medzhitov R. Recognition of microorganisms and activation of the immune response. Nature. 2007;449(7164):819-26.
[19] Feterowski C, Emmanuilidis K, Miethke T, Gerauer K, Rump M, Ulm K, Holzmann B, Weighardt H. Effects of functional Toll-like receptor-4 mutations on the immune response to human and experimental sepsis. Immunology. 2003;109(3):426-31.
[20] Brüne B. Nitric oxide: NO apoptosis or turning it ON? Cell Death Differ. 2003;10(8):864-9.
[21] Förstermann U, Closs EI, Pollock JS, Nakane M, Schwarz P, Gath I, Kleinert H. Nitric oxide synthase isozymes. Characterization, purification, molecular cloning, and functions. Hypertension. 1994;23(6 Pt 2):1121-31.
[22] Hickey MJ, Reinhardt PH, Ostrovsky L, Jones WM, Jutila MA, Payne D, Elliott J, Kubes P. Tumor necrosis factor-alpha induces leukocyte recruitment by different mechanisms in vivo and in vitro. J Immunol. 1997;158(7):3391-400.
[23] de Almeida CJ, Linden R. Phagocytosis of apoptotic cells: a matter of balance. Cell Mol Life Sci. 2005;62(14):1532-46.
[24] Sullivan KE, Jawad AF, Piliero LM, Kim N, Luan X, Goldman D, Petri M. Analysis of polymorphisms affecting immune complex handling in systemic lupus erythematosus. Rheumatology (Oxford). 2003;42(3):446-52.
[25] Aoyagi K. Inhibition of arginine synthesis by urea: a mechanism for arginine deficiency in renal failure which leads to increased hydroxyl radical generation. Mol Cell Biochem. 2003;244(1-2):11-5.
[26] Albert P, Calverley PM. Drugs (including oxygen) in severe COPD. Eur Respir J. 2008;31(5):1114-24.
[27] Allen BW, Demchenko IT, Piantadosi CA. Two faces of nitric oxide: implications for cellular mechanisms of oxygen toxicity. J Appl Physiol (1985). 2009;106(2):662-7.
[28] Woszczek G, Chen LY, Nagineni S, Shelhamer JH. IL-10 inhibits cysteinyl leukotriene-induced activation of human monocytes and monocyte-derived dendritic cells. J Immunol. 2008;180(11):7597-603.
[29] Jyothi MD, Khar A. Interleukin-2-induced nitric oxide synthase and nuclear factor-kappaB activity in activated natural killer cells and the production of interferon-gamma. Scand J Immunol. 2000;52(2):148-55.
[30] Hodge S, Hodge G, Scicchitano R, Reynolds PN, Holmes M. Alveolar macrophages from subjects with chronic obstructive pulmonary disease are deficient in their ability to phagocytose apoptotic airway epithelial cells. Immunol Cell Biol. 2003;81(4):289-96. Erratum in: Immunol Cell Biol. 2003 Dec;81(6):499.
[31] Lister KJ, James WG, Hickey MJ. Immune complexes mediate rapid alterations in microvascular permeability: roles for neutrophils, complement, and platelets. Microcirculation. 2007;14(7):709-22.
[32] Tejde A, Mathsson L, Ekdahl KN, Nilsson B, Rönnelid J. Immune complex-stimulated production of interleukin-12 in peripheral blood mononuclear cells is regulated by the complement system. Clin Exp Immunol. 2004;137(3):521-8.
[33] Maianski NA, Maianski AN, Kuijpers TW, Roos D. Apoptosis of neutrophils. Acta Haematol. 2004;111(1-2):56-66.
[34] Bazilyuk OV, Kotsuruba AV, Stepanenko LG, Talanov SA, Korchak YuP, Sagach VF. Age-dependence in alteration in nitric oxide synthesis in cardiovascular system during adaptation to physical training. Int J Physiol Phatophysiol. 2010; 1(4): 345–56.
[35] Blank R, Napolitano LM. Epidemiology of ARDS and ALI. Crit Care Clin. 2011;27(3):439-58.
[36] Boehme MWJ, Raeth U, Scherbaum WA, Galle PR, Stremmel W. Interaction of endothelial cells and neutrophils in vitro: kinetics of thrombomodulin, intercellular adhesion molecule-1 (ICAM-1), E-selectin, and vascular cell adhesion molecule-1 (VCAM-1): implications for the relevance as serological disease activity markers in vasculitides. Clin Exp Immunol. 2000;119(1):250-4.
[37] Manukhina EB, DowneyHF, Mallet RT, Malyshev IYu. Protective and damaging effects of the periodic hypoxia: Role of nitric oxide. Vestnik Ross AMN. 2007; 2: 25–33.
[38] Dergacheva TI, Shurlygina AV, Starkova EV, Verbitskaya LV, Yuklyaeva NV, Fazylov MF, Trufakin VA. Subpopulation composition of lymphocytes from regional lymph nodes, thymus and spleen in experimental inflammation of internal genitalia in female ratS. Immunologiya. 2000; (5):17–9.
[39] Yarilin AA. Homeostatic processes in the immune system. Control of the number of lymphocytes. Immunologiya. 2004; 25(5): 312–9.
[40] Roebuck KA. Oxidant stress regulation of IL-8 and ICAM-1 gene expression: differential activation and binding of the transcription factors AP-1 and NF-kappaB (Review). Int J Mol Med. 1999;4(3):223-30.
[41] Dabrowska M, Grubek-Jaworska H, Domagala-Kulavic J. Concentration of soluble intercellular adhesion mole-cule ICAM-1 in bronhoalveolar lavage fluid of patients with non-small cell lung cancer. Eur Respire J. 2004; 24: 82.
[42] Chedraoui-Silva S, Mantovani B. The role of complement in the modulation by fluid-phase IgG of the production of reactive oxygen species by polymorphonuclear leukocytes stimulated with IgG immune complexes. Braz J Med Biol Res. 2003;36(12):1665-72.
[43] Talaeva TV. Mechanisms of interaction of blood cells and vascular walls stand in the implementation of the inflammatory and immune responses. Ukr Rhevmatol Zh. 2001; 3–4(5–6): 45–52.
[44] Dixit K, Ali R. Antigen binding characteristics of antibodies induced against nitric oxide modified plasmid DNA. Biochim Biophys Acta. 2001;1528(1):1-8.
[45] Moser B, Loetscher P. Lymphocyte traffic control by chemokines. Nat Immunol. 2001;2(2):123-8.
[46] Mayansky AN. Mitochondrias of neutrophils: physiological features and significance in apoptosis. Immunologiya. 2004; 5: 307–11.
[47] Neumann P, Gertzberg N, Johnson A. TNF-alpha induces a decrease in eNOS promoter activity. Am J Physiol Lung Cell Mol Physiol. 2004;286(2):L452-9.
[48] Takabayashi A, Kawai Y, Iwata S, Kanai M, Denno R, Kawada K, Obama K, Taki Y. Nitric oxide induces a decrease in the mitochondrial membrane potential of peripheral blood lymphocytes, especially in natural killer cells. Antioxid Redox Signal. 2000 Winter;2(4):673-80.
[49] Larché M, Robinson DS, Kay AB. The role of T lymphocytes in the pathogenesis of asthma. J Allergy Clin Immunol. 2003;111(3):450-63.
[50] Mazepa MA, Mazepa AI. The role of apoptosis in the pathogenesis of systemic lupus erythematosus. Ukr Revmatol Zh. 2001; 3–4(5–6): 26–9.
[51] Dijstelbloem HM, van de Winkel JG, Kallenberg CG. Inflammation in autoimmunity: receptors for IgG revisited. Trends Immunol. 2001;22(9):510-6.
[52] Donn R, Alourfi Z, De Benedetti F, Meazza C, Zeggini E, Lunt M, Stevens A, Shelley E, Lamb R, Ollier WE, Thomson W, Ray D; British Paediatric Rheumatology Study Group. Mutation screening of the macrophage migration inhibitory factor gene: positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis. Arthritis Rheum. 2002;46(9):2402-9.
[53] Alexander JJ, He C, Adler S, Holers VM, Quigg RJ. Characterization of C3 receptors on cultured rat glomerular endothelial cells. Kidney Int. 1997;51(4):1124-32.
[54] Semydotskaya GD, Chernyakov IA, Bezdetko TV, Khymych TY. Autoimmun syndrome durimg allergic diseases. Astma Allergia. 2005; 2(4): 14–7.
[55] Nasonov E. Pathogenetic mechanisms of systemic vasculitis. Vrach. 2000; 5: 17–21.
[56] Li H, Förstermann U. Nitric oxide in the pathogenesis of vascular disease. J Pathol. 2000;190(3):244-54.
[57] Lebedev KA. Immunophisiologic basics course of chronic inflammatory processes and principles of their treatment. Allerg Immunol. 2005; 6(2):161–8.
[58] Bogdan C, Röllinghoff M, Diefenbach A. The role of nitric oxide in innate immunity. Immunol Rev. 2000;173:17-26.
[59] Abramov AB, Komyshyn OM, Rev EY. Effect of L-arginine on the structure of lymphoid populations of the thymus. Vistnyk nauk doslidgen. 2006; 3: 84–5.
[60] Biasi D, Carletto A, Caramaschi P, Bonella F, Bambara V, Pacor ML, Bambara LM. [Neutrophils in rheumatoid inflammation]. Recenti Prog Med. 2003;94(1):25-30. Review. Italian.
[61] Avdeeva MG, Shubych MG. Mechanisms pathological initiation of systemic inflammatory response syndrome. Clin lab diagnost. 2003; 3: 3–10.
[62] Jancar S, Sánchez Crespo M. Immune complex-mediated tissue injury: a multistep paradigm. Trends Immunol. 2005;26(1):48-55.
[63] Hayashi M. Oxidative stress in developmental brain disorders. Neuropathology. 2009;29(1):1-8.
[64] Stankevicius E, Kevelaitis E, Vainorius E, Simonsen U. [Role of nitric oxide and other endothelium-derived factors]. Medicina (Kaunas). 2003;39(4):333-41.
[65] Haruta K, Kobayashi S, Tajima M, Sakai A, Tamura N, Bando H, Hara M, Kawashima S, Takasaki Y, Hashimoto H. Effect of immune complexes in serum from patients with rheumatoid vasculitis on the expression of cell adhesion molecules on polymorphonuclear cells. Clin Exp Rheumatol. 2001;19(1):59-68.
[66] Zenkov NK, Menshchikova EB, Reutov VP. NO – synthase in normal and pathological conditions of different genesis. Vestn Ros AMN. 2000; 4: 30–4.
[67] Suchkov SV, Shogenov ZS, Khitrov AN, Vostrikov IL. Post-infectious autoimmune syndrome: pathogenetic features and modern protocols of clinical immunodiagnostics. Ter Arch. 2007; 4: 71–6.
[68] Talaev V, Zaichenko IE, Babaykin OM, Lomunova MA. The contents of the central and effector memory cells and functional properties of T-lymphocyte in newborns and adults with different methods of activation in vitro. Immunologiya. 2005; 5: 267–74.
[69] Brüne B, Sandau K, von Knethen A. Apoptotic cell death and nitric oxide: activating and antagonistic transducing pathways. Biochemistry (Mosc). 1998;63(7):817-25. Review.
[70] Bogdan C, Röllinghoff M, Diefenbach A. The role of nitric oxide in innate immunity. Immunol Rev. 2000;173:17-26.
[71] Zhang C, Reiter C, Eiserich JP, Boersma B, Parks DA, Beckman JS, Barnes S, Kirk M, Baldus S, Darley-Usmar VM, White CR. L-arginine chlorination products inhibit endothelial nitric oxide production. J Biol Chem. 2001;276(29):27159-65.
[72] Litvinenko GI. Morphocytochemical peculiarities of human blood lymphocytes in different phases of days and years cycles under normal conditions and in the development of immunodeficiency: Author. dys. Novosibirskij medicinskiy institute. 1998; 16: 40p .
[73] Malinski T. The Nitric Oxide-superoxide in dysfunctional endothelium. Abstr First Ukr. Congres Cell Biol. 2004; 207–8.
[74] Nakashima T, Yokoyama A, Inata J, Ishikawa N, Haruta Y, Hattori N, Kohno N. Mucins carrying selectin ligands as predictive biomarkers of disseminated intravascular coagulation complication in ARDS. Chest. 2011;139(2):296-304.
[75] Efremova YP, Lichkovska NE, Fafula RV, Vorobets ZD. NO-synthase systemin humans in the development of pathological processes. Exp Clin Physiol Biochem. 2012; 1: 68–73.
[76] Tesfamariam B, DeFelice AF. Endothelial injury in the initiation and progression of vascular disorders. Vascul Pharmacol. 2007;46(4):229-37.
[77] Titov VN. Nitric oxide in the endothelium-dependent vasodilation response. Basics unity of endothelial and smooth muscle cells in a paracrine regulation of metabolism. Clin Llab Diagn. 2007; 2:23–39.
[78] Sivak VV. Method of free circulating endothelial cells in the blood determination. Patent N 2007 02080 (Ukraine) 25,012 U IPC G01N33/55. Bulleten. N11: 2.
[79] Dignat-George F, Sampol J. Circulating endothelial cells in vascular disorders: new insights into an old concept. Eur J Haematol. 2000;65(4):215-20.
[80] Bozza FA, Gomes RN, Japiassú AM, Soares M, Castro-Faria-Neto HC, Bozza PT, Bozza MT. Macrophage migration inhibitory factor levels correlate with fatal outcome in sepsis. Shock. 2004;22(4):309-13.
[81] Plotnikoff NP, Faith RE, Murgo AG, Good RA. Cytokines: Stress and Immunity. Boca Raton: CRC Press, 2006: 2nd Edition: 405 p.
[82] Maksimenko AV, Turashev AD. Endothelial glycocalyx of the circulatory system: Detection, the components, structural organization. Russ J Bioorganic Chem. 2014; 40(2): 119–28.
[83] Wu CV. Nitric Oxide and Inflammation. Curr Med Chem Anti Inflamm Anti Allergy Agents. 2004; 3(3):217-222.
[84] Ke X, Terashima M, Nariai Y, Nakashima Y, Nabika T, Tanigawa Y. Nitric oxide regulates actin reorganization through cGMP and Ca(2+)/calmodulin in RAW 264.7 cells. Biochim Biophys Acta. 2001;1539(1-2):101-13.
[85] Lupinskaya ZA, Zarifyan AG, Gurovich TC,. Schleifer SG. The endothelium: function and dysfunction B.: KRSU, 2008; 373 p.
[86] Bachschmid M, Thurau S, Zou MH, Ullrich V. Endothelial cell activation by endotoxin involves superoxide/NO-mediated nitration of prostacyclin synthase and thromboxane receptor stimulation. FASEB J. 2003;17(8):914-6.
[87] Bucci M, Roviezzo F, Posadas I, Yu J, Parente L, Sessa WC, Ignarro LJ, Cirino G. Endothelial nitric oxide synthase activation is critical for vascular leakage during acute inflammation in vivo. Proc Natl Acad Sci U S A. 2005;102(3):904-8.
[88] Gao L, Flores C, Fan-Ma S, Miller EJ, Moitra J, Moreno L, Wadgaonkar R, Simon B, Brower R, Sevransky J, Tuder RM, Maloney JP, Moss M, Shanholtz C, Yates CR, Meduri GU, Ye SQ, Barnes KC, Garcia JGN. Macrophage migration inhibitory factor in acute lung injury: expression, biomarker, and associations. Translational Research 2007; 150(1): 18-29.
[89] Bethel K, Luttgen MS, Damani S, Kolatkar A, Lamy R, Sabouri-Ghomi M, Topol S, Topol EJ, Kuhn P. Fluid phase biopsy for detection and characterization of circulating endothelial cells in myocardial infarction. Phys Biol. 2014;11(1):016002. doi:
[90] Kravchenko NA, Yarmash NV. Biochemical and molecular genetic mechanisms of synthesis of nitric oxide in endothelial NO-synthase in norm and cardiovascular diseases. Ukr Therapeut Zh. 2007; 1: 82–3.
[91] Russo S, Bussolati B, Deambrosis I, Mariano F, Camussi G. Platelet-activating factor mediates CD40-dependent angiogenesis and endothelial-smooth muscle cell interaction. J Immunol. 2003;171(10):5489-97.
[92] Boos CJ, Soor SK, Kang D, Lip GY. Relationship between circulating endothelial cells and the predicted risk of cardiovascular events in acute coronary syndromes. Eur Heart J. 2007;28(9):1092-101.
[93] O'Donnell VB, Freeman BA. Interactions between nitric oxide and lipid oxidation pathways: implications for vascular disease. Circ Res. 2001;88(1):12-21.
[94] Damani S, Bacconi A, Libiger O, Chourasia AH, Serry R, Gollapudi R, Goldberg R, Rapeport K, Haaser S, Topol S, Knowlton S, Bethel K, Kuhn P, Wood M, Carragher B, Schork NJ, Jiang J, Rao C, Connelly M, Fowler VM, Topol EJ. Characterization of circulating endothelial cells in acute myocardial infarction. Sci Transl Med. 2012;4(126):126ra33.
[95] Kitamoto S, Egashira K, Kataoka C, Koyanagi M, Katoh M, Shimokawa H, Morishita R, Kaneda Y, Sueishi K, Takeshita A. Increased activity of nuclear factor-kappaB participates in cardiovascular remodeling induced by chronic inhibition of nitric oxide synthesis in rats. Circulation. 2000;102(7):806-12.
[96] Ivanov AN, Norkyn IA, Puchynyan DM, Shirokov VJ, Zhdanova OJ. Adhesive endothelial moleculesofvascular-wall. Usp Fiziol Nauk. 2014; 45(4): 34–49.
[97] Gallagher PM, Lowe G, Fitzgerald T, Bella A, Greene CM, McElvaney NG, O'Neill SJ. Association of IL-10 polymorphism with severity of illness in community acquired pneumonia. Thorax. 2003;58(2):154-6.
[98] Festa A, D'Agostino R Jr, Williams K, Karter AJ, Mayer-Davis EJ, Tracy RP, Haffner SM. The relation of body fat mass and distribution to markers of chronic inflammation. Int J Obes Relat Metab Disord. 2001;25(10):1407-15.
[99] Rönnelid J, Tejde A, Mathsson L, Nilsson-Ekdahl K, Nilsson B. Immune complexes from SLE sera induce IL10 production from normal peripheral blood mononuclear cells by an FcgammaRII dependent mechanism: implications for a possible vicious cycle maintaining B cell hyperactivity in SLE. Ann Rheum Dis. 2003;62(1):37-42.
[100] DiMeo D, Tian J, Zhang J, Narushima S, Berg DJ. Increased interleukin-10 production and Th2 skewing in the absence of 5-lipoxygenase. Immunology. 2008;123(2):250-62.
[101] Schmidt P, Youhnovski N, Daiber A, Balan A, Arsic M, Bachschmid M, Przybylski M, Ullrich V. Specific nitration at tyrosine 430 revealed by high resolution mass spectrometry as basis for redox regulation of bovine prostacyclin synthase. J Biol Chem. 2003;278(15):12813-9.
[102] Fantuzzi G. Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol. 2005;115(5):911-9.
[103] Bloodsworth A, O'Donnell VB, Freeman BA. Nitric oxide regulation of free radical- and enzyme-mediated lipid and lipoprotein oxidation. Arterioscler Thromb Vasc Biol. 2000;20(7):1707-15.
[104] Forstermann U. Endotelial NO synthase as a source of NO and superoxide. Eur J Clin Pharmacol. 2006; 62(1): 5–12.
[105] Nagy G, Koncz A, Telarico T, Fernandez D, Ersek B, Buzás E, Perl A. Central role of nitric oxide in the pathogenesis of rheumatoid arthritis and systemic lupus erythematosus. Arthritis Res Ther. 2010;12(3):210. doi:
[106] Norman MU, Lister KJ, Yang YH, Issekutz A, Hickey MJ. TNF regulates leukocyte-endothelial cell interactions and microvascular dysfunction during immune complex-mediated inflammation. Br J Pharmacol. 2005;144(2):265-74.
[107] Kaur C, Ling EA. Antioxidants and neuroprotection in the adult and developing central nervous system. Curr Med Chem. 2008;15(29):3068-80. PubMed PMID: 19075654.
[108] Kalinichenko OV, Myshunina TN, Dronko MD. The activity of nitric oxide synthase concentration in tissue of persons with thyroid carcinomas. Fiziol Zh. 2016; 62(3): 9–19
[109] Moncada S. Nitric oxide and cell respiration: physiology and pathology. Verh K Acad Geneeskd Belg. 2000;62(3):171-9; discussion 179-81. Review.
[110] Strutynska NA, Kotsyuruba AV, Bud'ko AJ, Mys LA, Sagach VF. Dysfunction of mitochondria in the heart of aging whith accompanied withtensionsof constitutive NO-synthase on the background of oxidative and nitrosoactive stress. Fiziol Zh. 2016; 62(2): 3–11
[111] Diefenbach A, Schindler H, Donhauser N, Lorenz E, Laskay T, MacMicking J, Röllinghoff M, Gresser I, Bogdan C. Type 1 interferon (IFNalpha/beta) and type 2 nitric oxide synthase regulate the innate immune response to a protozoan parasite. Immunity. 1998;8(1):77-87.
[112] Shapoval LN. Contribution of nitric oxide and mitochondrial permeability transition to the cardiovascular control in hypertension and experimental hyperglycemia. Advances in biomedical research, University of Cambridge, UK, February 23–25. 2010; 127–132.
[113] Poon BV, Raharjo E, Patel KD, Tavener S, Kubes P. Complexety of inducible nitric oxide synthase. Circulation. 2003; 108: 1107–15.
[114] Price S, Mitchell JA, Anning PB, Evans TW. Type II nitric oxide synthase activity is cardio-protective in experimental sepsis. Eur J Pharmacol. 2003;472(1-2):111-8.
[115] Lubrano V, Vassalle C, Blandizzi C, Del Tacca M, Palombo C, L'Abbate A, Baldi S, Natali A. The effect of lipoproteins on endothelial nitric oxide synthase is modulated by lipoperoxides. Eur J Clin Invest. 2003;33(2):117-25.
[116] Kawana S. Vascular endothelial cell injury in allergie vasculitis. Journal of the Nippon Medical School. 1998; 65(3): 1950–2000.
[117] Goshovska Yu, Korkach Yu, Shimanskaya T, Kotsuruba A, Sahach V. Effect of genipin at NO synthesis and ischemia-reperfusia induced oxidative stress in old rat heart. Int J Physiol Pathophysiol. 2010; 1(4): 335–44.
[118] Carvour M, Song C, Kaul S, Anantharam V, Kanthasamy A, Kanthasamy A. Chronic low-dose oxidative stress induces caspase-3-dependent PKCdelta proteolytic activation and apoptosis in a cell culture model of dopaminergic neurodegeneration. Ann N Y Acad Sci. 2008;1139:197-205.
[119] Wever RM, Lüscher TF, Cosentino F, Rabelink TJ. Atherosclerosis and the two faces of endothelial nitric oxide synthase. Circulation. 1998 Jan 6-13;97(1):108-12.
[120] Li H, Oehrlein SA, Wallerath T, Ihrig-Biedert I, Wohlfart P, Ulshöfer T, Jessen T, Herget T, Förstermann U, Kleinert H. Activation of protein kinase C alpha and/or epsilon enhances transcription of the human endothelial nitric oxide synthase gene. Mol Pharmacol. 1998;53(4):630-7.